![Photo](/media/story/24623/thumbnail-01-insulinmodell.jpg)
News • Insulin inhibitory receptor
New promising target for diabetes treatment
Researchers from Helmholtz Zentrum Muenchen, the Technical University of Munich and the German Center for Diabetes have discovered a novel and druggable insulin inhibitory receptor, named inceptor. The blocking of inceptor function leads to an increased sensitisation of the insulin signaling pathway in pancreatic beta cells. This might allow protection and regeneration of beta cells for diabetes…